Skip to content

Author

P. Tarantino

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#artificial intelligence Review Oct 2026

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

A two-stage AI model predicting pathological complete response to neoadjuvant therapy in breast cancer and transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays'gene selection constraints are developed.

Jungkyu Park, D. Biswas, J. Cappadona et al. · 0 citations
Review Sep 2026

Neoadjuvant antibody-drug conjugates for early-stage breast cancer: A systematic review and meta-analysis.

BACKGROUND Pathologic complete response (pCR) is a key endpoint of neoadjuvant therapy in early-stage breast cancer (EBC), associated with improved survival, particularly in triple-negative and human epidermal growth factor receptor 2 (HER2)-positive disease. More recently, antibody-drug conjugates (ADCs), established...

G. B. Silva, A. Simões, R. L. Nohmi et al. · 0 citations
Review Aug 2026

Antibody-drug conjugates in breast cancer: the first-line and curative setting.

PURPOSE OF REVIEW Antibody-drug conjugates (ADCs) have rapidly advanced from later-line salvage therapy into first-line metastatic and curative perioperative settings. This review appraises recent practice-changing data that collectively redefined treatment standards across Human epidermal growth factor receptor 2 (HER...

Nicole Odzer, P. Tarantino · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.